The cannabinoid CB1 receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus

SR141716A, a potent and selective antagonist of the brain cannabinoid receptor

Murielle Rinaldi‐Carmona, Francis Barth, Michel Héaulme et al. · FEBS Letters · 1994 · 1.8K citations · Full text

Medicine, Neuroscience, Pharmacology +14

Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A

Gian Luigi Gessa, Maria Antonietta Casu, Giovanna Carta et al. · European Journal of Pharmacology · 1998 · 143 citations

Life Sciences, Neuroscience, Pharmacology +12

Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain

M. Kathmann, U. Bauer, Eberhard Schlicker et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1999 · 89 citations

Life Sciences, Neuroscience, Pharmacology +12

Cannabinoid withdrawal is dependent upon PKA activation in the cerebellum

Eleni T. Tzavara, Emmanuel Valjent, Cedric Firmo et al. · European Journal of Neuroscience · 2000 · 82 citations

Medicine, Neuroscience, Pharmacology +17

Blockade of cannabinoid receptors by SR141716 selectively increases Fos expression in rat mesocorticolimbic areas via reduced dopamine D2 function

Richard Alonso, B. Voutsinos, Marie Fournier et al. · Neuroscience · 1999 · 81 citations

Life Sciences, Neuroscience, Pharmacology +16